Effects of Anti-TNF Alpha Drugs on Disability in Patients with Rheumatoid Arthritis: Long-Term Real-Life Data from the Lorhen Registry
This study involving 1033 patients with RA confirms the effectiveness of etanercept, adalimumab, and infliximab in reducing RA-related disability even in patients with a history of highly active and longstanding RA. Moreover, we found that the improvement in disability was biphasic, with a marked im...
Main Authors: | Matteo Filippini, Chiara Bazzani, Fabiola Atzeni, Piercarlo Sarzi Puttini, Antonio Marchesoni, Ennio Giulio Favalli, Roberto Caporali, Lorenzo Cavagna, Roberto Gorla |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2014/416892 |
Similar Items
-
Efficacy and safety of anti-TNF agents in the Lombardy rheumatoid arthritis network (LORHEN)
by: R. Caporali, et al.
Published: (2011-09-01) -
Early rheumatoid arthritis
by: P. Sarzi-Puttini, et al.
Published: (2011-09-01) -
Cost Effectiveness Analysis of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis. A Systematic Review Literature
by: Maurizio Benucci, et al.
Published: (2011-01-01) -
Treatment Comparison in Rheumatoid Arthritis: Head-to-Head Trials and Innovative Study Designs
by: Ennio Giulio Favalli, et al.
Published: (2014-01-01) -
Update on fibromyalgia
by: Fabiola Atzeni, et al.
Published: (2012-01-01)